<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02738840</url>
  </required_header>
  <id_info>
    <org_study_id>CRD_800</org_study_id>
    <nct_id>NCT02738840</nct_id>
  </id_info>
  <brief_title>A Post-Market Study Evaluating the MR Conditional Neuromodulation Systems</brief_title>
  <acronym>Prodigy MRI</acronym>
  <official_title>A Post-Market Study Evaluating the MR Conditional Neuromodulation Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A post market study evaluating the St Jude medical MR conditional neurostimulation systems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be performed as an international, multicenter, prospective and single-arm
      design. The study will be conducted as a Post Market Clinical Follow Up (PMCF) study and the
      results will be submitted to the Notified Body 'Technischer Uberwachungs-Verein (TUV)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the rate of the MRI scan-related adverse events</measure>
    <time_frame>1 month post MRI scan</time_frame>
    <description>The primary objective of the study is to confirm the safety of the SJM MR conditional neurostimulation system when performing a MRI scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the rate of successful device functionality checks</measure>
    <time_frame>1 month post MRI scan</time_frame>
    <description>The secondary objective is to confirm that the MRI scan does not affect the SJM MR conditional neurostimulation systems functionality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">49</enrollment>
  <condition>Chronic Pain</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <description>MRI scan</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The subject population enrolled in this study will be comprised of male and female
        subjects. Subjects have to meet specific eligibility criteria in order to participate in
        the study. 49 subjects will be enrolled. Data from only 1 scan per subject will be
        collected in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has been implanted with a commercially available SJM MR conditional
             neurostimulation system.

          -  Subject is scheduled to receive a MRI scan in compliance with the SJM IFU for the MR
             conditional neurostimulation system.

          -  Subject is at least 18 years of age

          -  Subject must be willing and able to comply with study requirements

          -  Subject must indicate his/her understanding of the study and willingness to
             participate by signing an appropriate informed consent form

        Exclusion Criteria:

          -  Subject has another implanted device (active or passive implanted device) that
             prohibits safe scanning

          -  Subject has previously experienced a MRI scan related adverse event
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Harbert</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Harbert</last_name>
    <email>nicole.harbert@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monique Van Bree</last_name>
    <email>mvanbree@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wilhelminenspital</name>
      <address>
        <city>Wien</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Burkhard Gustorff, DEAA</last_name>
      <phone>+43149150</phone>
      <phone_ext>4001</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Herwig Kloimstein, MD</last_name>
      <phone>+43149150</phone>
      <phone_ext>4008</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St Augustinus Ziekenhuis</name>
      <address>
        <city>Wilrijk</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Einrichtungen der Universit채t D체sseldorf, Dusseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Vesper, MD</last_name>
      <email>jan.vesper@med.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Gera -Zentrum f체r interdisziplin채re Schmerztherapie, Gera</name>
      <address>
        <city>Gera</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kretzschmar, MD</last_name>
      <email>Michael.Kretzschmar@wkg.srh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico S.S. Annunziata</name>
      <address>
        <city>Chieti</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>l'Azienda Ospedaliero- Universitaria Pisa</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuliano Carolis, MD</last_name>
      <email>giulianodecarolis@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Santa Maria Delle Croci</name>
      <address>
        <city>Ravenna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de Rocio</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2016</study_first_submitted>
  <study_first_submitted_qc>April 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2016</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

